Pubblicazioni Scientifiche
Dermatologia09 feb 2021
The dermoscopic inverse approach significantly
A recently introduced dermoscopic method for the diagnosis of early lentigo maligna
09 feb 2021
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated erythematous and scaly skin lesions accompanied by systemic manifestations.
04 feb 2021
A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences
A multicenter study of nevus-associated melanoma
04 feb 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study
The clinical spectrum of COVID-19-associated cutaneous manifestations
04 feb 2021
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides
Italian expert-based recommendations on the use of photo(chemo)therapy
26 gen 2021
Diagnosis of toenail onychomycosis by an immunochromatographic dermatophytes test strip
Diagnosis of toenail onychomycosis is based in current practice on direct microscopic examination (DME) and fungal cultures of nail samples.
26 gen 2021
Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides
Mycosis fungoides (MF) comprises 54% of cutaneous T cell lymphomas. Although the etiology is unknown, prior studies have shown that MF is more common in males than females, with greater incidence in African Americans (AAs).
26 gen 2021
Epithelioid Kaposi Sarcoma
Cutaneous Kaposi sarcoma (KS) covers a broad spectrum both clinically and pathologically. Some histological patterns of KS may be difficult to recognize and must be differentiated from other vascular neoplasms.
13 gen 2021
Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association
The co-existence of hidradenitis suppurativa (HS) and atopic dermatitis (AD) had been reported but was not investigated in controlled studies.
13 gen 2021
Pruritus Intensity Scales across Europe: A Prospective Validation Study
Chronic pruritus (CP) is a subjective symptom and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course
13 gen 2021
Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)
14 dic 2020
Androgenetic alopecia in women and men
Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines
14 dic 2020
Immune checkpoint-mediated psoriasis
A multicentric European study of 115 patients from European Network for Cutaneous ADverse Event to Oncologic drugs (ENCADO) group
14 dic 2020
Dermatoscopy of combined blue nevi: A multicenter study of the International Dermoscopy Society
Combined blue nevi may mimic melanoma and are relatively often biopsied for diagnostic reasons.
10 dic 2020
COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies
Since the onset of the 2019-nCoV disease (COVID-19), many skin manifestations have been reported in COVID-19 patients
10 dic 2020
Skin barrier immunity and ageing
The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m2, and is the first line of defence against a multitude of external pathogens and environmental insults.
02 dic 2020
The 2020 International Alliance for the Control of Scabies
Consensus Criteria for the Diagnosis of Scabies
02 dic 2020
Prurigo nodularis
Pathogenesis and management
02 dic 2020
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years
In this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;
24 nov 2020
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic
Risk Analysis from the PSO-BIO-COVID Observational Study